Drug Pipeline

Dihydroartemisinin Piperaquine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07322068 Perennial Malaria Chemoprevention in the Malaria Vaccine Era Malaria, Falciparum Not Yet Recruiting
Phase 3
NCT05690841 FocaL Mass Drug Administration for Vivax Malaria Elimination Plasmodium Vivax Malaria Recruiting
Early Phase 1
NCT07021430 Focal Mass Drug Administration for the Prevention of Malaria in Pregnancy Malaria Prevention Not Yet Recruiting
Sponsors Running Dihydroartemisinin Piperaquine Trials
University of California, San Francisco (1) University of North Carolina, Chapel Hill (1) Stanford University (1)
Get alerts when Dihydroartemisinin Piperaquine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free